Mindset Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56M Buy
1,302
+39
+3% +$39.8K 0.3% 36
2026
Q1
$1.16M Buy
1,263
+1
+0.1% +$1.01K 0.31% 38
2025
Q4
$1.36M Buy
1,262
+17
+1% +$16.3K 0.36% 29
2025
Q3
$950K Buy
1,245
+65
+6% +$48.4K 0.26% 38
2025
Q2
$920K Sell
1,180
-32
-3% -$24.9K 0.3% 32
2025
Q1
$1M Buy
1,212
+8
+0.7% +$6.66K 0.39% 25
2024
Q4
$930K Sell
1,204
-8
-0.7% -$6.62K 0.34% 22
2024
Q3
$1.07M Buy
+1,212
New +$1.09M 0.44% 16

Other funds holding LLY

Mindset Wealth Management's LLY Position: Q2 2026 in Review

Mindset Wealth Management increased its Eli Lilly (LLY) stake by 3.1% in Q2 2026, buying an estimated $39.8K and bringing the position to 1,302 shares worth $1.56M. The position accounts for 0.3% of the portfolio, ranked #36.

Mindset Wealth Management first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mindset Wealth Management held 1,302 shares of Eli Lilly worth $1.56M as of Q2 2026.
  • Mindset Wealth Management bought 39 Eli Lilly shares in Q2 2026, an estimated $39.8K.
  • Eli Lilly made up 0.3% of Mindset Wealth Management's portfolio in Q2 2026, its #36 holding.
  • Mindset Wealth Management first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mindset Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.